# Study of Disulfiram and Copper Gluconate in Patients With Treatment-Refractory Multiple Myeloma

> **NCT04521335** · PHASE1 · TERMINATED · sponsor: **University of Utah** · enrollment: 2 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Disulfiram
- **DRUG:** Copper Gluconate

## Key facts

- **NCT ID:** NCT04521335
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-05-21
- **Primary completion:** 2021-12-09
- **Final completion:** 2022-02-06
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Closed at PI's Request
- **Last updated:** 2023-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04521335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04521335, "Study of Disulfiram and Copper Gluconate in Patients With Treatment-Refractory Multiple Myeloma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04521335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*